An Analysis of the Symptomatic Domains Most Relevant to Charcot Marie Tooth Neuropathy (CMT) Patients

Sponsor
University of South Florida (Other)
Overall Status
Completed
CT.gov ID
NCT02429947
Collaborator
University of Rochester (Other), National Institute of Neurological Disorders and Stroke (NINDS) (NIH)
411
1
11
37.3

Study Details

Study Description

Brief Summary

The purpose of this study is to identify the issues that have greatest impact on QOL for patients with Charcot Marie Tooth (CMT) Disease. Patients who have -registered in the Inherited Neuropathies Consortium Contact Registry will be invited to participate.

Detailed Description

The protocol consists of two anonymous surveys. The first large scale survey is designed to identify items that best reflect the issues and symptoms with high impact upon QOL in CMT. A second brief survey focuses on the frequency and impact of muscle cramps on QOL in adult CMT. The surveys will be distributed via an online link to all adult CMT patients self-registered with the RDCRN contact registry. Those who complete the first two surveys will be requested to complete only the second brief survey on muscle cramps again 3 weeks after completing it the first time. Those who complete the brief muscle cramps survey a second time will be requested to complete it again 5 weeks later to assess variability in occurrence of muscle cramps.

The first large scale survey to identify items that best reflect the issues and symptoms with high impact upon QOL in CMT will be sent out in a second wave. This second wave will only contain the QOL survey and not the muscle cramp survey. The QOL survey will be distributed via an online link to three populations: adult CMT patients self-registered with the INC (RDCRN) Contact Registry who had not been registered at the time of the first enrollment period, adult patients who had been registered at the time of the first enrollment period and had received the survey, but had not returned it, and patients who were registered, but were under age 18 at the time of the first enrollment period and have turned 18 by the time of the second enrollment period.

Study Design

Study Type:
Observational
Actual Enrollment :
411 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
An Analysis of the Symptomatic Domains Most Relevant to Charcot Marie Tooth Neuropathy (CMT) Patients
Study Start Date :
Jul 1, 2012
Actual Primary Completion Date :
Jun 1, 2013
Actual Study Completion Date :
Jun 1, 2013

Arms and Interventions

Arm Intervention/Treatment
INC Contact Registry Participants

Adult CMT patients who have self-registered at the Inherited Neuropathies Consortium (INC) Contact Registry, a web-based contact registry developed and supported by the Data Management and Coordinating Center (DMCC) for the Rare Diseases Clinical Research Consortium (RDCRN), located at the University of South Florida.

Outcome Measures

Primary Outcome Measures

  1. Percentage of participants affected by specific symptoms of CMT. [1 year]

    The percentage of subjects within the sample who have reported experience with the symptom will be calculated.

Secondary Outcome Measures

  1. Severity of impact of each identified symptom of CMT [1 year]

    The symptoms will be rank ordered with symptoms that affect life severely receiving the highest rank.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with CMT that are 18 years or older and have joined the INC RDCRN Contact Registry.
Exclusion Criteria:
  • Does not have CMT.

  • Does not read or speak English.

Contacts and Locations

Locations

Site City State Country Postal Code
1 RDCRN Data Management and Coordinating Center , Epidemiology Center; University of South Florida Tampa Florida United States 33612

Sponsors and Collaborators

  • University of South Florida
  • University of Rochester
  • National Institute of Neurological Disorders and Stroke (NINDS)

Investigators

  • Study Chair: David Herrmann, MBBCh, University of Rochester

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of South Florida
ClinicalTrials.gov Identifier:
NCT02429947
Other Study ID Numbers:
  • INC6606
  • 5U54NS064808-07
  • INC6606
First Posted:
Apr 29, 2015
Last Update Posted:
Jun 14, 2017
Last Verified:
Jun 1, 2017

Study Results

No Results Posted as of Jun 14, 2017